Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy
Status:
Completed
Trial end date:
2017-01-20
Target enrollment:
Participant gender:
Summary
Following the findings of the clinical trials in drug development, this global
non-interventional cohort field study will investigate rivaroxaban under clinical practice
conditions in comparison with current standard of care for patients with acute venous
thoromboembolism (VTE).
The main goal is to analyze long-term safety in the use of rivaroxaban in the treatment of
acute VTE in routine clinical practice.